Quarterly report pursuant to Section 13 or 15(d)

Investment in account receivable (Details Narrative)

v3.24.3
Investment in account receivable (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Feb. 15, 2022
Apr. 10, 2015
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Jun. 11, 2024
Dec. 31, 2023
Oct. 14, 2023
Jan. 10, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants price per share     $ 0.62   $ 0.62           $ 0.64    
Impairment of investments               $ 22,718 $ 139,148        
Gain on investment $ 41,930                        
Purchase obligation, to be paid                         $ 117,000
Annual installment payments 2024                         117,000
Annual installment payments 2025                         117,000
Annual installment payments 2026                         $ 117,000
Impairment     $ (250,208)   $ (250,208)         $ 250,208    
Face value     287,200 [1]   287,200 [1]         287,200 285,400 [1]    
Unamortized discount     36,992   36,992         $ 36,992 $ 46,551    
Amortization of debt discount     $ 0 $ 10,484 $ 9,559 $ 27,091              
Other Income [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Gain on investment             $ 41,930 $ 22,718          
Series D Warrants [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants price per share     $ 0.02 $ 1.60 $ 0.02 $ 1.60           $ 0.02  
Exchange Agreement [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Account receivable with annual installment payments   $ 117,000                      
Annual installment receivable, term   11 years                      
Shares issued, value   $ 1,287,000                      
Shares issued, shares   757,059                      
Investment in account receivable discount percent     17.87%   17.87%                
Exchange Agreement [Member] | Series D Warrants [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Warrants issued   757,059                      
Warrants price per share   $ 1.60                      
Warrants redemption price   $ 0.10                      
[1] Coincident with the June 11, 2024 impairment, accounts receivable of $2,300 was reclassed and concurrently impaired. Prior to the full impairment, the Company reduced the face value of its investment in account receivable by an additional $100 per month for five receivable payment installments at the nine months ended September 30, 2024.